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INTRODUCTION 
Multiple sclerosis (MS) is a chronic inflammatory disease 
of the central nervous system in which defensive cells of 
the body mistakenly attack myelin (protective sheaths of 
neural fibers in the brain and spinal cord.1 
The disease usually occurs in the second to third decades 
of life and occurs between the ages of 20 and 45 years 
and the prevalence rate in women is three times that of 
men. The symptoms of the disease depend on the 
involved organ including motor speech disorders. The 
prevalence of MS is different depending on the 
geographical area and the population and in Iran 120 
people are infected per 100,000 people. Also, the disease 
is prevalent among young people and adolescents. The 
spread of the disease is increasing in our country and 
even had the highest prevalence among Middle Eastern 
countries. The etiology of the disease is not exactly clear 
but this illness has self-safety background and factors 
such as genetics, infection, vitamin D deficiency and 
environmental factors including climate change have 
main role in its incidence.2-5 Diagnosis of MS is based on 
clinical symptoms and confirmed by the brain and spinal 
MRI and the CSF test. Generally no definitive treatment 
for MS but by discovery of new drugs this disease is 
somewhat curable and controllable and prescribed drugs 
such as prednisone, dexamethasone and methyl 
prednisolone are used to reduce the duration of illness 
acute attacks. Increasing illness in recent years has led to 
a high level of psychological problems such as anxiety, 
stress and depression in MS patients and most of patients 
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with disapproval of the disease focus their attention on 
future problems.6,7 
In addition, change in marital and sexual function of 
patients, decreased self-esteem and state of mind, limited 
social activities and economic problems have also 
reduced the quality of life in patients.8,9 In the first half of 
the twentieth century it was believed that pregnancy with 
MS (PRIMS) is associated with a risk of relapse of the 
disease and sometimes abortion was also supported. But 
recent studies have shown that pregnancy is associated 
with a safe and effective condition for MS patients which 
is caused by the effect on T lymphocyte. The high relapse 
of multiple sclerosis is reduced during pregnancy and 
after delivery it returns to pre pregnancy state 
immediately.10 MS illness is not a obstacle to pregnancy 
and even attacks during pregnancy reach to low rate. 
More known of MS and its effects on women's health, 
fertility and menstruation is important. Women’s 
awareness of MS and possible changes from it can 
minimize the likelihood of their worries.11 Increasing the 
four-fold prevalence of female infections in women and 
high incidence in pregnancy are issues that can increase 
the worry of women especially pregnant women that 
having awareness about MS and its issues on pregnancy 
can help to decide of women in the future about their 
lives. There is no evidence that MS has a negative effect 
on pregnancy and or MS leads to abortion, fetal death or 
congenital disorders. The results of studies show that 
pregnancy, delivery and fetal problems are not the same 
in women with MS and other women were similar. Many 
studies have shown that pregnancy in MS patients is 
associated with a low risk of progression and 
exacerbation of the disease. Also, the rate of relapse 
increases during the first trimester after delivery and 
pregnancy has not effect on the course of disease and 
long term disability in life.12-15  
METHODS 
Study design and samples 
This study was descriptive-analytical that has been done 
on 150 pregnant women over 18 years of age who were 
randomly selected form referred women to the health 
centers of Ardabil city during 2017.  
Data collection method 
Data collected by a questionnaire including age, 
education level, occupation, MS disease course and 
medical treatment, knowledge and beliefs about the 
effects of disease on pregnancy, MS and premature 
delivery, breast feeding effects on MS, ways of 
preventing the disease and the factors affecting it.  
The questionnaire included 27 multiple choice questions 
that one of the options in each question was correct and 
women's awareness score in this study variable from 1 to 
19. Low awareness of 1 to 7, moderate awareness of 
grades 8 to 14 and high awareness of score 15 to 19.  
Statistical analysis  
Data were analyzed by descriptive and analytical 
statistical methods in SPSS version 16.  
Ethically approve 
All women complete the consent form and then 
participated in the study. 
RESULTS 
The average age of women in the study was 25.8±6.2 and 
48.7% of pregnant women were under 25 years of age. 
44% of women has diploma and 32.7% were employed. 
The highest level of knowledge were among employed 
women with a bachelor's degree and more than 35 years 
old but there was no significant relationship between 
education, occupation and age of women with knowledge 
level (Table 1). 25.3% of the women believed that the 
elderly in comparison to other age groups significantly 
more susceptible to the disease (Table 2). 20% of women 
considered gender as one of the most effective factors in 
the MS disease and 44.7% believed that women were 
more likely to develop MS than men and 20.7% pointed 
that menopause were considered as the most important 
period of the disease in women which was statistically 
significant (Table 3). 43.3% of women believed that 
women with MS could get married and become pregnant 
(38.7%).28.7% of women believed that if women with 
MS had a baby they could take care of their newborn 
which was statistically significant (Table 3). The 
knowledge level of women about prevention ways of 
illness was 36% and avoidance of stress and anxiety with 
60.4% was the most important preventive factors (Figure 
1). 
Stress, anxiety and genetics were one of the most 
important factors affecting MS disease and avoid from 
stress and anxiety with 60% was the best ways of 
prevention of MS which was statistically significant 
(Figure 2). The results of this study showed that the most 
source of knowledge with 36.4% were friends and 
relatives. 63.3% pointed that the awareness level of 
health centers to the disease was inappropriate and 68.7% 
pointed that the government's support for patients was 
low and limited which was statistically significant. The 
highest and the lowest correct responses were 62.7% for 
non-communicable disease and 13.3% for anesthesia in 
women with childbirth (Table 1). 39.3% of women 
known MS without definite treatment and 40% believed 
that the disease did not cause to a complete disability, 
which was statistically significant (Table 2). The results 
of this study showed that 19.3% believed that drugs used 
to treat MS cause to abortion and 20.7% considered 
vaginal delivery as an appropriate delivery method for 
women with MS (Table 3). 
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Table 1: Relation between demographic data and knowledge rate about MS. 
Level demographic data 
Low Moderate High Total 
P value 
N % N % N % N % 
Occupation  
Employee 11 22.4 31 63.3 7 14.3 49 32.7 
0.17 
None-employee 47 46.5 43 42.6 11 10.9 101 67.3 
Education 
Under diploma 13 50 11 42.3 2 7.7 26 17.3 
0.1 Diploma 29 43.9 31 47 6 9.1 66 44 
BS and higher degree 16 27.6 32 55.2 10 17.2 58 38.7 
Age groups  
<25 33 42.5 30 41.1 10 13.7 73 48.7 
0.2 25-35 23 34.3 38 56.7 6 9 67 44.7 
>35 2 20 6 60 2 20 10 6.7 
Table 2: The knowledge rate of women about general information about MS. 
General information N % P value 
MS is prevalent in women than men. 
True 67 44.7 
0.001 
False 83 55.3 
MS is prevalent in agent groups.  
True 38 25.3 
0.001 
False 112 74.7 
MS is higher in cold people. 
True 22 14.7 
0.001 
False 128 85.3 
MS is a none-communicable disease. 
True 94 62.7 
0.001 
False 56 37.3 
There is no certain cure for MS True 59 39.3 0.001 
False 91 60.7 
MS is a controllable disease. 
True 61 40.7 
0.027 
False 89 59.3 
MS don’t deal to complete disability in patients. 
True 60 40 
0.001 
False 90 60 
Table 3: The knowledge rate of women about relation between MS and pregnancy and childbirth. 
MS and pregnancy N % P value 
Patients with MS could marry in future. 
True 65 43.3 
0.1 
False 85 56.7 
The illness in women is more visible during menopause. 
True 31 20.7 
0.001 
False 119 79.3 
Women with MS could be pregnant. 
True 58 38.7 
0.007 
False 92 61.3 
MS hasn’t effect on pregnancy. 
True 44 29.3 
0.001 
False 106 70.7 
MS is modulated in the third trimester of pregnancy. True 46 30.7 0.078 
False 104 69.3 
Drug used in MS patients’ cause to abortion in pregnant women. 
True 29 19.3 
0.001 
False 121 80.7 
Drugs used by MS patients has effect on fetal status 
True 46 30.7 
0.001 
False 104 69.3 
The best delivery method was vaginal delivery. 
True 31 20.7 
0.004 
False 119 79.3 
Anesthesia for childbirth is not forbidden in women with MS. 
True 20 13.3 
0.001 
False 130 86.7 
The incidence of complications in a newborn baby is not different 
from that of normal people. 
True 28 18.7 
0.001 
False 122 81.3 
A mother with MS can maintain her baby. 
True 43 28.7 
0.001 
False 107 71.3 
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Figure 1: Effective factors on MS based women idea. 
 
Figure 2: Knowledge rate of women about the ways of 
prevention MS. 
DISCUSSION 
Multiple sclerosis is one of the most common chronic 
diseases in the nervous system and like any other chronic 
disease, it effects the various aspects of a person's life. In 
this study, the knowledge of pregnant women in a high 
status was 20% among women over 35 years of age, 
63.3% in average status among employed women and in 
the low level was 50% among women under the diploma .
Similar to the study, in the study of Amani et al, the level 
of knowledge with 64% was in the moderate level. There 
was a significant relationship between education level 
and knowledge and there was no significant relationship 
between employee status, education with knowledge 
level.16 The most source of women about MS was friends 
and acquaintances, Awareness of patients and their 
friends and relatives about the disease can play an 
important role in controlling the disease because 
knowledge and awareness of relatives of patients who are 
the main careers of patients, can have an appropriate 
response to worry, fatigue, irritability and other patient 
behaviors. In the present study women's awareness nature 
of non-communicable of MS disease was 62.7% which 
was lower than some internal studies such as Amani et al 
with 88% awareness. Awareness about the characterized 
of this disease is important because it affects the quality 
of the relationship between patients and other people. If 
people do not have enough information about the disease 
they will prevent them from getting close to them and 
thus increase their depression and anxiety in MS 
patients.16 MS is one of the chronic diseases of the central 
nervous system due to its high incidence at young age 
leads to a reduction in individual and social efficiency. 
Most of MS patients are in second or fourth decades of 
life that this age range is a person's effectiveness period. 
In this study, 25% of women believed that MS is a 
diseases among elderly and 20.7% of them knew it a 
disease in menopausal women.17 Many of autoimmune 
diseases have age distribution and in most cases, women 
are more likely to be damage than men.18 Population 
based studies show that the prevalence of multiple 
sclerosis in women compared to men is almost constant it 
which may be due to the effects of sexual and genetic 
hormones on body immune responses. One of the 
symptoms that prove sex hormones are involved in the 
pathogenesis of MS was that clinical manifestations in 
women often appear at the same time as the changes in 
the balance of estrogen - lutein hormones that during the 
menstrual period, after pregnancy and during the period 
of osteoporosis. In the present study, 44.7% of the 
women pointed that the disease was associated with 
women and 26.7% of them know the female hormones 
was one of the factors affecting the disease.1,18-19 Various 
studies have shown that the frequency relapse of multiple 
sclerosis has decreased during pregnancy especially in 
the third trimester of pregnancy and after delivery 
increased immediately and after three months of delivery 
it returns to pre-pregnancy status. In addition to other 
studies, 30.7% of pregnant women in the present study 
stated that MS adjusted during the third trimester of 
pregnancy.20,21 Although MS is a common and complex 
neuropathy and its exact etiology is still unknown but 
epidemiological information show that both genetic and 
environmental factors are important in the incidence of 
the disease. Smoking has an important relationship with 
MS and other autoimmune disorders. In this study, stress 
and anxiety and genetics respectively with 56% and 
32.7% are the most important factors which effecting the 
disease and avoiding smoking is one of the most 
important ways of preventing MS.4,22,23 The results of this 
study showed that 40% of women believed that there was 
no certain treatment for the disease but the disease was 
controllable and did not cause to complete disability in 
patients. Studies have shown that the overall rate of 
disability progression even in pregnant women with 
multiple sclerosis during pregnancy, despite the increase 
in recurrence rate in the first trimester after delivery is 
comparable to the expected range of disability rates for 
non-pregnant women with the disease but the decision of 
a woman with MS for pregnancy is seriously affected by 
the disease activity. So the opinion of 43.3% and 38.7% 
of the women who believed that women with MS disease 
could get married and become pregnant seem to be 
correct.20 Selective cesarean delivery is associated with 
high risk in women with MS but the cultural, geographic 
and ethnicity impacts in choosing cesarean delivery 
cannot be ignored. In most studies the rate of cesarean in 
women is between 9.6%-41.1% for example in a study by 
Finkelsztejn et al was 41.5% and in Anat Achiron was 
56 
32.7 
30 
26.7 
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20 
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13.7%. In this study, 20.7% of the women knew vaginal 
delivery as the most suitable delivery method for 
women.24,25 The average abortion rate in pregnant women 
with MS is reported to be between 20-30% and in some 
cases pregnancy is at risk due to the use of MS related 
drugs. In a recent study, 19.3% of women said that drug 
used to treat MS cause to abortion.24 Common and meta-
analysis study show that women with MS do not have 
significant maternal and neonatal complications. The rate 
of mortality and abnormalities in these women was 
between 1.13% to 6.25% of total births and in many 
studies, there is no relationship between the mortality and 
abnormalities of newborns with maternal use of drug. 
The results of the Albrecht et al study in 2010 showed 
that women's knowledge about the relationship between 
MS and pregnancy was very low which was in line with 
our study results.26 
William et al also found that pregnancy did not affect the 
improvement of MS and it can be useful at sometimes 
and the results showed that women's awareness was in 
moderate level which was inline our study results.27 All 
the research shows that the baby's low birth weight and 
the birth of a premature baby in mothers was low and can 
be ignored. In a recent study, 18.7% of women reported 
that the occurrence of complications in a newborn due to 
woman with MS did not different from normal 
women.24,28,29 Recent results showed that the knowledge 
of pregnant women about MS was in moderate to low 
rate and 63.7% of women assessed the knowledge of 
health centers inappropriate. By increasing the provided 
educational programs and increasing the awareness of 
pregnant women about MS by health centers in different 
areas is necessary in future. 
CONCLUSION  
The results of this study showed that pregnant women 
had moderate to low knowledge rate about MS disease 
and its effect on the fetus and prevention of it. However 
health centers do not have enough experience and 
knowledge to the referrals about MS and the 
government's support for establishing prevention and 
treatment of MS is very low which need to take effective 
actions in this regard in the future. 
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